Donepezil delay to nursing home placement study is flawed

J Am Geriatr Soc. 2004 May;52(5):845; author reply 845-6. doi: 10.1111/j.1532-5415.2004.52230_3.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / mortality
  • Caregivers
  • Cholinesterase Inhibitors / administration & dosage
  • Cholinesterase Inhibitors / therapeutic use*
  • Controlled Clinical Trials as Topic
  • Donepezil
  • Humans
  • Indans / administration & dosage
  • Indans / therapeutic use*
  • Institutionalization
  • Nootropic Agents / administration & dosage
  • Nootropic Agents / therapeutic use*
  • Nursing Homes
  • Piperidines / administration & dosage
  • Piperidines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Research
  • Time Factors
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Indans
  • Nootropic Agents
  • Piperidines
  • Donepezil